[ad_1]
The Saudi Food and Drug Authority (SFDA) has lodged a complaint with the health authorities to suspend the use of 3 preparations produced by DoxSaudi Pharma following the decision of the pharmaceutical companies and the product company to suspend the drug chains. production of the company.
The decision to suspend all production lines of Dokis Saudi Pharmaceutical Industries was due to the company's non-compliance with GMPs, including suspension of the company's registration and the obligation to withdraw all activities from the companies. 3 products to all beneficiaries.
[ad_2]
Source link